Using Serology to Assist with Complicated Post-Exposure Prophylaxis for Rabies and Australian Bat Lyssavirus

PLoS Neglected Tropical Diseases

Volumn 7, Issue 2, 2013, Pages

  Conroy, Niall ^a   Vlack, Susan ^a   Williams, Julian M ^b   Patten, John J ^a   Horvath, Robert L ^c   Lambert, Stephen B ^a,d  

^a QUEENSLAND HEALTH   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c THE PRINCE CHARLES HOSPITAL   (Australia)

^d LADY CILENTO CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CD4 ANTIGEN; PREDNISOLONE; PROMETHAZINE; RABIES IMMUNOGLOBULIN; RABIES VACCINE; RANITIDINE; STEROID;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; DOG BITE; DRUG EXPOSURE; EGG ALLERGY; FACE EDEMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RESPONSE; MALE; POST EXPOSURE PROPHYLAXIS; RABIES; RABIES VIRUS; RASH; SEROLOGY; URTICARIA; WOUND CARE;

EID: 84874769209     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002066     Document Type: Article

References (31)

1. Australian Government (2007) Exotic Animal Diseases Bulletin. Australian Bat Lyssavirus(ABLV). Australian veterinary journal 85: N20-22.
2. Mills DJ, Lau CL, Weinstein P, (2011) Animal bites and rabies exposure in Australian travellers. The Medical journal of Australia 195: 673-675.
3. National Health and Medical Research Council (2009) 3.1: Australian bat lyssavirus infection and rabies. In: The Australian Immunisation Handbook. 9th edition. Canberra: Australian Government Department of Health and Ageing, Office of Health Protection. Available: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook-lyssavirus. Accessed 16 December 2012.
4. Communicable Diseases Network of Australia (2012) Rabies and Australian Bat Lyssavirus SoNG: CDNA National Guidelines for Public Health Units. Australian Commonwealth Department of Health and Ageing. Available: http://www.health.gov.au/internet/main/publishing.nsf/Content/1188BC2B96C74C17CA257A4E0082D217/File/ABLV-rabies-song.pdf. Accessed 16 December 2012.
5. World Health Organization (1984) WHO expert committee on rabies. World Health Organization technical report series 709: 1-104.
6. Rupprecht CE, Briggs D, Brown CM, Franka R, Katz SL, et al. (2010) Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports/Centers for Disease Control 59: 1-9.
7. Northern Territory Department of Health and Families (2010) Reduction in the number of doses of vaccine for rabies post- exposure prophylaxis. The Northern Territory Disease Control Bulletin 17: 14.
8. Warrell MJ, Warrell DA, (2004) Rabies and other lyssavirus diseases. Lancet 363: 959-969.
9. Jones RL, Froeschle JE, Atmar RL, Matthews JS, Sanders R, et al. (2001) Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine. Vaccine 19: 4635-4643.
10. Rupprecht CE, Gibbons RV, (2004) Clinical practice. Prophylaxis against rabies. The New England Journal of Medicine 351: 2626-2635.
11. Centers for Disease Control and Prevention (2008) Human rabies prevention- United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports 57: 1-28.
12. Fraser GC, Hooper PT, Lunt RA, Gould AR, Gleeson LJ, et al. (1996) Encephalitis caused by a Lyssavirus in fruit bats in Australia. Emerging infectious diseases 2: 327-331.
13. Hooper PT, Lunt RA, Gould AR, Samaratunga H, Hyatt AD, et al. (1997) A new lyssavirus- the first endemic rabies-related virus recognized in Australia. Australian veterinary journal 95: 209-218.
14. Samaratunga H, Searle JW, Hudson N, (1998) Non-rabies Lyssavirus human encephalitis from fruit bats: Australian bat Lyssavirus (pteropid Lyssavirus) infection. Neuropathology and applied neurobiology 24: 331-335.
15. Hanna JN, Carney IK, Smith GA, Tannenberg AE, Deverill JE, et al. (2000) Australian bat lyssavirus infection: a second human case, with a long incubation period. The Medical journal of Australia 172: 597-599.
16. Ewald B, Durrheim D, (2008) Australian Bat Lyssavirus: examination of post-exposure treatment in NSW. New South Wales public health bulletin 19: 104-107.
17. Brookes SM, Parsons G, Johnson N, McElhinney LM, Fooks AR, (2005) Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine 23: 4101-4109.
18. Welch RJ, Anderson BL, Litwin CM, (2009) An evaluation of two commercially available ELISAs and one in-house reference laboratory ELISA for the determination of human anti-rabies virus antibodies. Journal of medical microbiology 58: 806-810.
19. Centers for Disease Control and Prevention (1987) Human rabies despite treatment with rabies immune globulin and human diploid cell rabies vaccine- Thailand. MMWR Morbidity and mortality weekly report 36: 759-760, 765.
20. Gacouin A, Bourhy H, Renaud JC, Camus C, Suprin E, et al. (1999) Human rabies despite postexposure vaccination. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology 18: 233-235.
21. Shantavasinkul P, Tantawichien T, Wacharapluesadee S, Jeamanukoolkit A, Udomchaisakul P, et al. (2010) Failure of rabies postexposure prophylaxis in patients presenting with unusual manifestations. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 50: 77-79.
22. De SG, Dallaire F, Cote M, Skowronski DM, (2008) Bat rabies in the United States and Canada from 1950 through 2007: human cases with and without bat contact. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 46: 1329-1337.
23. Kureishi A, Xu LZ, Wu H, Stiver HG, (1992) Rabies in China: recommendations for control. Bulletin of the World Health Organization 70: 443-450.
24. Deshmukh DG, Damle AS, Bajaj JK, Bhakre JB, Patil NS, (2011) Fatal rabies despite post-exposure prophylaxis. Indian journal of medical microbiology 29: 178-180.
25. Wilde H, Sirikawin S, Sabcharoen A, Kingnate D, Tantawichien T, et al. (1996) Failure of postexposure treatment of rabies in children. Clinical infectious diseases 22: 228-232.
26. Gautret P, Shaw M, Gazin P, Soula G, Delmont J, et al. (2008) Rabies postexposure prophylaxis in returned injured travelers from France, Australia, and New Zealand: a retrospective study. Journal of travel medicine 15: 25-30.
27. Gautret P, Lim PL, Shaw M, Leder K, (2011) Rabies post-exposure prophylaxis in travellers returning from Bali, Indonesia, November 2008 to March 2010. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 17: 445-447.
28. Centers for Disease Control and Prevention (2011) General recommendations on immunization- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports 60: 1-64.
29. Pancharoen C, Thisyakorn U, Tantawichien T, Jaijaroensup W, Khawplod P, et al. (2001) Failure of pre- and postexposure rabies vaccinations in a child infected with HIV. Scandinavian journal of infectious diseases 33: 390-391.
30. Tantawichien T, Jaijaroensup W, Khawplod P, Sitprija V, (2001) Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 33: E122-124.
31. Sirikwin S, Likanonsakul S, Waradejwinyoo S, Pattamadilok S, Kumperasart S, et al. (2009) Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus. Vaccine 27: 4350-4354.